These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29629626)

  • 21. Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease.
    Kara M; Dogru T; Genc H; Sertoglu E; Celebi G; Gurel H; Kayadibi H; Cicek AF; Ercin CN; Sonmez A
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1144-8. PubMed ID: 26062078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil to lymphocyte ratio as a reliable marker to predict insulin resistance and fibrosis stage in chronic hepatitis C virus infection.
    Abdel-Razik A; Mousa N; Besheer TA; Eissa M; Elhelaly R; Arafa M; El-Wakeel N; Eldars W
    Acta Gastroenterol Belg; 2015 Dec; 78(4):386-92. PubMed ID: 26712048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil to Lymphocyte Ratio (NLR) and its Correlation with Child Turcotte Pugh (CTP) Score in Prediciting Severity of Decompensated Liver Cirrhosis.
    Sahani S; Das D
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio.
    Yoo JJ; Cho EJ; Lee B; Kim SG; Kim YS; Lee YB; Lee JH; Yu SJ; Kim YJ; Yoon JH
    Gut Liver; 2018 Nov; 12(6):714-721. PubMed ID: 30400732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
    Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
    Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
    Liu X; He L; Han J; Wang L; Li M; Jiang Y; Wang X; Yang Z
    PLoS One; 2017; 12(2):e0170605. PubMed ID: 28231294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of neutrophiltolymphocyte ratio in the severity of non-alcoholic fatty liver disease among type 2 diabetes patients.
    Kahraman NK; Kahraman C; Koçak FE; Coşgun S; Şanal B; Korkmaz M; Bayhan Z; Zeren S
    Acta Gastroenterol Belg; 2016; 79(3):295-300. PubMed ID: 27821024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease.
    Alsebaey A; Elhelbawy M; Waked I
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):207-211. PubMed ID: 29240565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
    Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
    Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling Neutrophil-to-Lymphocyte Ratio Changes in Response to Nucleoside Analog Therapy for Chronic Hepatitis B Infection.
    Marallag M; Patel A; Choi M; Wong MN; Seetharam AB
    In Vivo; 2017; 31(6):1175-1177. PubMed ID: 29102942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High neutrophil-lymphocyte ratio indicates poor prognosis for acute-on-chronic liver failure after liver transplantation.
    Lin BY; Zhou L; Geng L; Zheng ZY; Jia JJ; Zhang J; Yao J; Zheng SS
    World J Gastroenterol; 2015 Mar; 21(11):3317-24. PubMed ID: 25805939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil-to-lymphocyte ratio: an accurate method for diagnosing infection in cirrhosis.
    Magalhães RS; Magalhães J; Sousa-Pinto B; Cúrdia Gonçalves T; Rosa B; Cotter J
    Postgrad Med; 2021 Aug; 133(6):613-618. PubMed ID: 33843439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comparison of Brunt's Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a Proposed NAS Scoring that Includes Fibrosis in Non-Alcoholic Fatty Liver Disease Staging.
    Santiago-Rolón A; Purcell D; Rosado K; Toro DH
    P R Health Sci J; 2015 Dec; 34(4):189-94. PubMed ID: 26602577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.
    Alkhouri N; Morris-Stiff G; Campbell C; Lopez R; Tamimi TA; Yerian L; Zein NN; Feldstein AE
    Liver Int; 2012 Feb; 32(2):297-302. PubMed ID: 22097893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.
    Siddiqui MS; Patidar KR; Boyett S; Luketic VA; Puri P; Sanyal AJ
    Liver Int; 2016 Apr; 36(4):572-9. PubMed ID: 26713759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation.
    Chen LZ; Jing XB; Wu CF; Zeng YC; Xie YC; Wang MQ; Chen WX; Hu X; Zhou YN; Cai XB
    Dis Markers; 2021; 2021():6591784. PubMed ID: 34992694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fibrosis markers of nonalcoholic steatohepatitis.
    Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
    World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.